Weekly market update: AI Is Losing Its Luster

February 28, 2026

Up:

Arcellx +77.49%: Gilead has announced its intent to acquire the biotech firm for USD 115 per share, representing a 79% premium. The transaction is valued at EUR 7.8 billion and is expected to close in the second quarter of 2026.…

Source



Original URL: Click here to visit original article